4746 — Formosa Laboratories Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapValue Trap

Annual balance sheet for Formosa Laboratories, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	812	1,093	1,631	2,510	2,703
Net Total Accounts Receivable
Net Total Receivables	785	803	827	1,024	1,258
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	3,148	3,619	4,151	5,244	5,868
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5,917	5,986	5,978	6,095	6,233
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	10,286	12,017	12,751	13,636	13,895
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3,040	2,386	3,142	3,241	2,356
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	5,081	4,622	5,230	6,065	6,211
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	5,205	7,395	7,521	7,571	7,684
Total Liabilities & Shareholders' Equity	10,286	12,017	12,751	13,636	13,895
Total Common Shares Outstanding